Human B-Lymphocyte Antigen CD20 (MS4A1) Protein
234€ (1 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Name
Human B-Lymphocyte Antigen CD20 (MS4A1) Protein
Category
Proteins and Peptides
Provider
Abbexa
Reference
abx680080
Tested Applications
SDS-PAGE
Description
Human B-Lymphocyte Antigen CD20 (MS4A1) Protein is a recombinant protein produced in Sf9, Insect cells.
Documentos del producto
Instrucciones
Data sheet
Especificaciones del producto
| Category | Proteins and Peptides |
| Immunogen Target | B-Lymphocyte Antigen CD20 (MS4A1) |
| Host | Insect |
| Origin | Human |
| Conjugation | Unconjugated |
| Expression | Recombinant |
| Purity | > 90% (SDS-PAGE) |
| Size 1 | 1 µg |
| Size 2 | 5 µg |
| Size 3 | 50 µg |
| Form | Liquid |
| Tested Applications | SDS-PAGE |
| Availability | Shipped within 5-10 working days. |
| Dry Ice | No |
| Alias | B1,S7,Bp35,CD20,FMC7,CVID5,LEU-16,B-lymphocyte antigen CD20,B-lymphocyte surface antigen B1,Leukocyte surface antigen Leu-16,Membrane-spanning 4-domains subfamily A member 1 |
| Background | Protein MS4A1 |
| Status | RUO |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |
Background
MS4A1, also known as CD20, is a membrane-bound protein that plays a key role in the regulation of B-cell development, activation, and differentiation. It is predominantly expressed on the surface of B lymphocytes from the pre-B cell stage through to the mature B cell stage, and its expression is lost once B cells differentiate into plasma cells. CD20 is widely studied for its role in both normal immune function and its involvement in a variety of B-cell-related diseases, including non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia (CLL), and autoimmune diseases. MS4A1 is a member of the membrane-spanning 4A (MS4A) family of proteins, which includes several proteins with similar structural features, although their specific functions may differ across cell types and tissues. CD20 has become a major therapeutic target, particularly in B-cell depletion therapies, due to its restricted expression pattern and its role in the immune response. The development of anti-CD20 monoclonal antibodies, such as rituximab, has revolutionized the treatment of B-cell malignancies and certain autoimmune conditions.
Productos relacionados
B-Lymphocyte Antigen CD20 (MS4A1) Antibody
MS4A1 Antibody is a Rabbit Polyclonal antibody against MS4A1. This gene encodes a member of the membrane-spanning 4A gen…
Ver producto
B-Lymphocyte Antigen CD20 (MS4A1) Antibody
CD20 (MS4A1, membrane-spanning 4-domains, subfamily A, member 1) is a member of the membrane-spanning 4A gene family. Me…
Ver producto
B-Lymphocyte Antigen CD20 (MS4A1) Antibody
CD20 Antibody is a Mouse Monoclonal antibody against CD20.…
Ver producto